Apoptosis is important to sculpt tissues and eliminate unnecessary cells as well as for tumor suppression. However, mammalian development is surprisingly intact in mice deficient in the essential proapoptotic regulators Bax and Bak (Lindsten et al., 2000) . Thus, in the absence of apoptosis, many types of developmental cell death can still occur by other mechanisms. For example, different pathways to cell death are involved in lumen formation in glandular epithelia. Indeed, cells with defective apoptosis can be diverted to necrotic cell death, but the roles of necrosis and perhaps other modes of cell elimination in cancer and development are poorly understood. Reporting in this issue, Brugge and colleagues describe a new mode of nonapoptotic cell elimination called "entosis" that resembles cell cannibalism and the cell-in-cell phenotype observed in some tumors. Their work provides yet another example of the fact that cell death is not just about apoptosis anymore.
In mammary epithelia, clearing of the lumen, which occurs for the purpose of secretion, is a normal developmental process in puberty. Clearing occurs when luminal cells that have detached from the ECM undergo a specialized form of apoptotic cell death termed anoikis. During anoikis, cells detach from the ECM and lose survival signaling through integrins (Gilmore, 2005) . Luminal clearing has been studied in great detail because three-dimensional mammary epithelial duct morphogenesis in the presence of an ECM can be modeled in vitro (Nelson and Bissell, 2006) . Detachment from the ECM, or metabolic or oxidative stress, triggers elimination of these central acinar cells through caspase-dependent apoptosis or necrotic cell death if apoptosis is defective (Figure 1 ) (Debnath et al., 2002; Karantza-Wadsworth et al., 2007; Mailleux et al., 2007) . In mammary acini, it is the acinar center where metabolic stress initiates the catabolic process of autophagy that sustains cell survival, which when inhibited can either accelerate apoptosis or induce necrotic cell death of apoptosis-defective cells (Figure 1 ) (Karantza-Wadsworth et al., 2007) . Unregulated cell proliferation and decreased apoptosis in epithelial cancers such as those of breast are typified by filling of the lumen with cells. Therefore, identifying and characterizing the various mechanisms for cell elimination in glandular epithelia and establishing whether these events are deregulated in cancers, or can be reactivated therapeutically, is of great importance. A key question is whether entosis is another mechanism to eliminate cells that detach from the ECM in vivo. This cell absorption through entosis may contribute to the elimination of ductal epithelial cells in normal development or may be a mechanism of tumor suppression. Tumors with cytological features of cell cannibalization resembling entosis have been reported, but the mechanism and significance is unknown (Abodief et al., 2006) . To address the potential occurrence of entosis in cancer, Overholtzer and colleagues examined pleural fluid exudates from individuals with breast cancer. Tumor cells in these pleural fluid samples are in suspension and lack ECM attachment. Indeed, cells within cells typical of entosis were observed to varying degrees and could also be detected in primary tumors. Now the challenge is to establish the functional significance of entosis. The authors observed an increase in cell colony formation by mammary cell lines in suspension in the presence of Rho and ROCK inhibitors that block entosis, consistent with a role for entosis in cell elimination.
It is unclear if entosis is merely a means for cell elimination or if cannibalism of the invading cell provides an advantage to the host cell, perhaps through nutrient recycling during metabolic stress. If entosis were a mechanism of eliminating detached cancer cells, then stimulating it would be therapeutically advantageous and inhibiting it (with Rho or ROCK inhibitors, for example) would be detrimental. Epithelial tumor progression is associated with the epithelial-tomesenchymal transition. Thus, it will figure 1. Regulation of cell Death in Mammary Acinar cells Three-dimensional mammary ductal morphogenesis modeled in vitro leads to multicellular spheroid acinar formation in the presence of an extracellular matrix (ECM). Cells at the external rim of the acinus form tight and adherens junctions (TJ and AJ, respectively) and establish a polarized epithelial layer surrounded by a basement membrane, an organizational state that maintains survival signaling in these cells (Nelson and Bissell, 2006) . The central acinar cells are subjected to stresses and are eliminated by several different mechanisms, generating a hollow lumen. The stress of cell detachment and the loss of survival signaling by integrins activate a form of cell death by apoptosis termed anoikis, resulting in lumen formation (Debnath et al., 2002; Nelson and Bissell, 2006) . The central acinar cells are also subjected to metabolic stress induced by hypoxia and likely also nutrient deprivation that initiates the catabolic cellular self-eating process of autophagy to recycle intracellular nutrients to support survival (Karantza-Wadsworth et al., 2007) . Autophagy can enable long-term survival of apoptosis-defective central acinar cells facilitating luminal filling. Inhibiting autophagy (and thereby nutrient recycling) in metabolically stressed, apoptosis-defective central acinar cells results in necrotic cell death (Karantza-Wadsworth et al., 2007) . ECM detachment of central acinar cells and adherens junction formation can also lead to cell invasion and lysosome-mediated degradation and cell death of the invading cell by the process of entosis . The failure to eliminate luminal cells can be one factor that contributes to filling of the lumen, which is a step in the progression of epithelial cancers. be interesting to determine whether the transition to a mesenchymal fate provides an advantage to cancer cells enabling them to escape entosis, or whether entosis is deregulated in cancers. As with the initial description of a new phenomenon, which often raises more questions than it provides answers, defining the process of entosis and the genes that control it will be needed to establish its relevance in vivo.
Hematopoietic stem cells (HSCs) were once believed to avoid the ravages of age by residing in bone marrow, where they generate cells of nearly all hematopoietic lineages. Yet, HSCs are also present in blood and other tissues. Studies that measure the numbers of HSCs in blood reveal that nearly all HSCs in the bone marrow periodically enter the cell cycle (Cheshier et al., 1999; Wright et al., 2001) . In this issue, Massberg, von Andrian, and their colleagues chart new patrol routes for HSCs, deduce how their migration is controlled, and establish a raison d'être outside of the bone marrow (Massberg et al., 2007) .
There is recent support for the long-held view that HSCs reside in association with osteoblasts near trabecular bone-the tissue in the inner cavities of bones (Adams and Scadden, 2006) . This niche is thought to represent a nurturing environment, providing signals for HSC survival, relative quiescence, and self renewal (Figure 1) . However, methods for identifying HSCs have progressively improved, and we now know that larger numbers of HSCs can be found in the more centrally located perivascular regions of bones (Kiel et al., 2005) . Although the bone marrow is still considered to be the principal site for blood cell formation, spleen and liver are also important sites for this process during fetal development. Moreover, blood cell formation in these tissues can be transiently reactivated (termed extramedullary hematopoiesis) under conditions of unusual demand for blood cells such as during a parasitic infection or during myelofibrosis.
Although mobilization of HSCs for therapeutic transplantation is being extensively studied (Winkler and Levesque, 2006) , mechanisms associated with normal egress into the circulation are poorly understood. It is likely that cell adhesion molecules, proadhesive chemokines, crowding, neutrophilderived proteases, and innervation of niches by the sympathetic nervous system all determine whether HSCs remain sessile or are induced to migrate. The blood of a mouse contains between 100 and 400 HSCs at any one time, but they reside there for only seconds, and some eventually return to the bone marrow (Wright et al., 2001 Hematopoietic stem cells (HSCs) exist in the bone marrow and circulate in the blood. In this issue, Massberg et al. (2007) report that HSCs also travel through the lymphatic system. Furthermore, migration of HSCs-which express Toll-like receptors-allows the recognition of pathogenic molecules in peripheral tissues thereby promoting the local generation of innate immune cells at the site of infection.
